myCare iMedicWare

Excellent Ophthalmic EMR, Responsive CEO, Medical Director & Staff

Pros

It's vital for a medical practice that the vendor's staff responds to our needs, and iMedicware excels at this. The CEO understands ophthalmic practices well and is responsive to our needs. The Medical Director educates us on compliance with Meaningful Use, PQRS, and eRx, and can represent us in audits if necessary, which is a tremendous asset. Our ASC also uses iMedicware, and it's user-friendly for both staff and surgeons. Having the same vendor for both the practice and ASC is cost-effective and efficient.

Cons

Despite challenges posed by Meaningful Use requirements, these are external factors beyond the control of the vendor. Choosing iMedicware for both our practice and ASC has proven to be the right decision.

Review of iDoc software

Pros

As the President of a medical billing company specializing in Ophthalmology, I demoed all recommended EMR and practice management systems available today. We chose iMedicWare for its easy transition from our legacy system, competitive pricing, and responsive customer service. After two years of use, iMedicWare has exceeded our expectations. Our productivity has increased significantly with fewer staff members. From a management perspective, the system allows us to track days in AR and physician productivity, key indicators for our business. The iMedicWare support team has been instrumental in easing our transition and providing individualized support.

Cons

While the standard reporting function could benefit from additional robustness, the proactive assistance from customer support in custom reporting is commendable.

iMedicWare is a Step ahead

Pros

I see iMedicWare as an evolving product that innovates by offering Providers and Practice managers not only the basics but also advanced concepts to improve their practice. Their customer service is excellent; they are always available and follow up on issues promptly.

Cons

The system consistently requires enhancements in its training regimen, particularly when introducing new products into its portfolio.